Back to SYRE
VOYA INVESTMENT MANAGEMENT LLC → SYRE
VOYA INVESTMENT MANAGEMENT LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$5.7M
Q3 2026
Peak value
$24.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $388K |
| Q4 2025 | $506K |
| Q1 2026 | $1.2M |
| Q1 2026 | $1.5M |
| Q2 2026 | $6.8M |
| Q2 2026 | $7.4M |
| Q2 2026 | $24.1M |
| Q3 2026 | $6.2M |
| Q3 2026 | $19.1M |
| Q3 2026 | $5.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.7M | 63.7K | — | — |
| Q3 2026 | $19.1M | 214.8K | — | — |
| Q3 2026 | $6.2M | 69.7K | — | — |
| Q2 2026 | $24.1M | 271.8K | — | — |
| Q2 2026 | $7.4M | 83.8K | — | — |
| Q2 2026 | $6.8M | 76.1K | — | — |
| Q1 2026 | $1.5M | 30.4K | — | — |
| Q1 2026 | $1.2M | 23.6K | — | — |
| Q4 2025 | $506K | 15.4K | — | — |
| Q4 2025 | $388K | 11.8K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M